Abstract
Introduction:
Group A streptococcus (GAS) remains a global burden, particularly in developing countries, with long-term morbidity and mortality complications. Different strains and immune responses to GAS can lead to various disease patterns, from predominantly throat and skin manifestations to renal and cardiac involvement. Myocarditis associated with glomerulonephritis can progress to carditis, which may present with signs and symptoms similar to rheumatic heart disease. Although uncommon, this condition can deteriorate into dilated cardiomyopathy, potentially leading to cardiogenic shock and death, necessitating early recognition, intervention, and preventive measures.Case Presentation:
We report three pediatric cases of post-streptococcal infection with cardiac manifestations. The first case involves an 8-year-old female with palpitations and a recurring cough, diagnosed with acute rheumatic carditis. The second case is a 10-year-old female presenting with hemoptysis and edema in the lungs and extremities due to acute rheumatic carditis and prior suspected vegetation. The third case is a 9-year-old male initially diagnosed with post-streptococcal glomerulonephritis (PSGN), who deteriorated into dilated cardiomyopathy with an ejection fraction of 32% and multiple organ dysfunction syndrome. All three patients recovered well, received prophylactic management, and were referred for further investigation.Conclusions:
Identifying specific features on echocardiography can help differentiate between rheumatic heart disease (RHD) and PSGN-associated cardiac involvement. Additionally, echocardiography is a more readily available and cost-effective screening method, especially in endemic populations. Early recognition and management of post-streptococcal cardiac complications may prevent long-term morbidity and mortality.Keywords
Rheumatic Heart Disease Post-streptococcal Glomerulonephritis Echocardiography
1. Introduction
Group A streptococcus (GAS) typically causes tonsillitis and pharyngitis. In developed countries, immune-mediated complications of streptococcus remain a complex issue, both during acute infection (e.g., scarlet fever) and following the infection, such as rheumatic heart disease (RHD) and post-streptococcal glomerulonephritis (PSGN). Group A streptococcus complications are prevalent worldwide, with RHD affecting fewer than 5 million cases in 2013, while PSGN affects approximately 9.5 cases per 100,000 population annually in developing countries. This does not account for several recent scarlet fever outbreaks, which are concerning (1, 2). Very few cases show concurrent PSGN and RHD due to differences between nephrogenic and rheumatogenic strains, making cardiac complications in PSGN uncommon. Unfortunately, the inflammatory response caused by group A streptococcus, including PSGN, can progress to dilated cardiomyopathy and fulminant myocarditis with high mortality (3). Although echocardiograms have become more accessible and show benefits for diagnosing RHD, they are rarely used for PSGN (4). We describe three cases of Indonesian children with cardiac-related post-streptococcal complications, compare the results, and review them based on echocardiogram findings.
2. Case Presentation
2.1. Case 1
An 8-year-old female presented with recurring palpitations and exhaustion for two weeks. She had a history of polyarthralgia one week prior and recurring flu-like symptoms. Other than this, her medical history was unremarkable. Her vital signs showed normotension and a normal respiration rate, but she had tachycardia. Physical examination revealed mild underweight, a pansystolic murmur graded IV/VI at the mitral valve, and a murmur graded III/VI at the tricuspid valve, with S3 gallops but no rhonchi.
Further examination revealed increased anti-streptolysin O (ASO) and C-reactive protein (CRP) levels, along with thrombocytosis and 10% monocytes (Table 1). A chest X-ray (Figure 1A) showed cardiomegaly with left atrial (LA) enlargement, consistent with her ECG findings. Transthoracic echocardiography (Figure 1B) revealed LA and left ventricular (LV) dilatation with normal systolic function, global normokinesis, and an ejection fraction (EF) of 63.5%. Severe mitral regurgitation (MR) with a flail anterior mitral leaflet (AML) was noted, along with moderate tricuspid regurgitation (TR), mild aortic and pulmonary regurgitation, and mild pulmonary hypertension. She was diagnosed with acute rheumatic fever carditis and treated with erythromycin 200 mg qid, furosemide 20 mg, captopril 6.25 mg bid, spironolactone 6.25 mg, high-dose aspirin, and prednisone. She was managed effectively, and her antibiotic regimen was adjusted to a prophylactic dose. Due to limited facilities, she was referred for long-term prophylaxis.
Parameters | Case 1 | Case 2 | Case 3 |
---|---|---|---|
Hemoglobin (g/dL) | 10.7 | 11.9 | 11.7 |
WBC (/µL) | 13,000 | 9,500 | 11,400 |
WBC diff count | Monocyte 10% | Lymphocyte 47% | Within normal range |
Platelets (/µL) | 591,000 | 673,000 | 389,000 |
ASTO (IU/mL) | 800 | 800 | 400 |
Electrolyte: K, Na, Cl, Ca (mmol/L) | Normal | Normal | K 5.8 |
Blood urea (mg/dL) | Normal | Normal | 82 |
Creatinine (mg/dL) | Normal | Normal | 1.5 |
C-reactive protein | (+) | (+) | -- |
Others | -- | -- | Albumin: 2.7 g/dL; urinalysis; haematuria 3+, proteinuria 1+ |
A, case 1 chest x-ray showed cardiomegaly and pulmonary congestion; B, echocardiography PLAX showed left atrial (LA) and left ventricular (LV) dilatation, global normokinetic, and severe mitral regurgitation (MR). Excessive motion in flail anterior mitral leaflet (AML) with suspicion of distal tip restriction or thickening and impinged towards LV outflow tract during diastole (green arrow).
2.2. Case 2
A 10-year-old female was admitted to the emergency department with hemoptysis, worsening dyspnea, and ankle swelling for three days, along with a history of polyarthralgia. She had been evaluated by a pediatrician and cardiologist a month earlier, but admission for acute rheumatic fever (ARF) with suspected vegetation was refused. Her medications included aspirin, furosemide, ramipril, erythromycin prophylaxis, spironolactone, and prednisone, which had run out about a week ago. Vital signs were normotensive, with mild tachypnea, tachycardia, and normal oxygen saturation. Physical examination revealed increased jugular venous pressure, bibasilar rales, bilateral ankle swelling, and pansystolic murmurs at the mitral and tricuspid valves graded V/VI, but no additional signs of infective endocarditis. Her weight at admission was 27 kg.
Her laboratory results are shown in Table 1. The ECG showed LA enlargement, and the chest X-ray (Figure 2A) indicated cardiomegaly. An echocardiogram performed last month (Figure 2B) revealed four-chamber dilatation with normal systolic function, global normokinesis (EF 69%), severe MR with suspected vegetation on a flail AML, severe TR, and mild pulmonary regurgitation (PR). A follow-up echocardiogram during admission showed no vegetation, but the flail AML and posterior mitral leaflet (PML) abnormalities persisted. She was diagnosed with suspected reactivation of rheumatic heart disease. We increased the erythromycin dose and added sildenafil 6.25 mg bid. After discharge, she remained well and was referred to a tertiary center for long-term prophylaxis and treatment consideration.
A, case 2 chest x-ray showed cardiomegaly and pulmonary congestion; B, echocardiography PLAX one month ago showed RA, left atrial (LA), and left ventricular (LV) dilatation, global normokinetic, and mitral regurgitation (MR) severe with suspected vegetation on the anterior mitral leaflet (AML) (blue arrow).
2.3. Case 3
A 9-year-old male presented to the emergency department with dyspnea, vomiting for three days, and newly recognized swollen eyes. He had experienced a sore throat a week ago and had been treated with over-the-counter medication. His family reported no new medications or history of allergies. Vital signs revealed diastolic hypertension with tachycardia, mild tachypnea, and normal oxygen saturation. Physical examination showed right-side rales, bilateral palpebral edema, and an S3 gallop, but no ankle swelling or increased jugular venous pressure. His BMI was normal, and he weighed 25 kg at admission.
The chest X-ray (Figure 3A) revealed pleural effusion and cardiomegaly. Laboratory results are shown in Table 1, and the patient was diagnosed with acute post-streptococcal glomerulonephritis. Treatment with fluid restriction, antibiotics, captopril, and furosemide was initiated. On day 3, his condition and edema worsened, with leukocytosis (30,100), metabolic acidosis, and elevated CRP, ALT, AST, and blood urea. He was evaluated by a cardiologist, and an echocardiogram (Figure 3B) revealed four-chamber dilatation, global hypokinesis (EF 32%), severe MR and TR, mild PR, and slight pericardial effusion. We increased the furosemide dose, corrected hypoalbuminemia, and added digoxin, ivabradine, and low-dose aspirin. The antibiotic was changed from cefotaxime to meropenem. By day 9, the patient was discharged, with improvements noted on follow-up chest X-rays. He was referred for long-term prophylaxis.
A, case 3 chest X-ray showed cardiomegaly, pulmonary congestion, and pleural effusion; B, echocardiography PLAX showed four chamber dilatation and global hypokinetic, slight pericardial effusion, severe mitral regurgitation (MR) and severe tricuspid regurgitation (TR), without any excessive motion and no thickening or impingement (red arrow).
3. Discussion
The mitral leaflet motion and morphology, particularly the presence of excessive leaflet motion and distal tip morphology, are beneficial as indicators of acute mitral changes and are pathognomonic for RHD in the pediatric setting. These findings help differentiate between RHD and PSGN. Whether the vegetation is part of ARF or not, further investigation is still warranted. Additionally, an echocardiogram should be considered in PSGN with deteriorating or heart failure symptoms so that it can be managed early before progressing into dilated cardiomyopathy.
Rheumatic heart disease is recognized as a global burden with long-term morbidity and 275,000 deaths yearly, with a high prevalence in Australia and Asia, compared to acute PSGN, which has declined worldwide except in low-to-middle-income countries where the risk of nephritis from throat infection is around 5%. Transmission through the respiratory tract and skin infection may increase the odds in a high-density population with poor living conditions. Furthermore, genetics may play a role in the RHD immunopathologic response, as Australian Indigenous and Indonesian people are part of the Asia-Pacific origin (1, 2).
Prevalence studies of subclinical RHD in Indonesia, Tanzania, and Bharat revealed 20 cases per 250, 34 per 1,000, and 20 per 1,000 children, respectively. Additionally, the prevalence of clinical RHD is around 1 per 1,000 children in both Tanzania and Bharat, contrasting with ARF incidence, which is only 30 per 100,000. The difference in numbers is concerning since subclinical cases rarely show symptoms and may be detected years afterward, which warrants prevention by early screening for subclinical RHD in endemic countries, especially in schools (4-6).
Echocardiography remains a highly specific and sensitive tool for diagnosing RHD. All patients exhibited severe mitral regurgitation (excluding other causes), which is pathognomonic for RHD based on the World Heart Federation’s criteria. Flail leaflet motion is defined as excessive leaflet tip motion due to elongation of the primary chordae, resulting in displacement of the tip, particularly the AML. This condition leads to severe regurgitation and normalized ejection fraction when compared to case 3, which showed normal leaflet motion and reduced ejection fraction due to eccentric myocardial remodeling with annular dilatation. Additionally, the impingement of AML might be part of the “flail” due to chordae elongation (unrestricted motion) and valvular inflammation. These findings help differentiate between carditis in PSGN and ARF (i.e., rheumatic valvulitis). The study by Hunter et al. (7) also supported the anterior ‘distal tip’ configuration in the PLAX view as a definitive RHD criterion in all 43 school children. These findings are considered useful for diagnosis and predicting progression in individuals aged ≤ 20 years due to fewer differential etiologies (4, 7, 8). Meanwhile, PSGN is rarely associated with severe carditis, as seen in the research by Idhate et al., and the absence of specific morphology/valvulitis findings in the paper adds to the benefit of echocardiographic assessment (8).
Valvulitis is caused by antibody deposition, molecular mimicry, and reactivity from T cells, while cardiac involvement in PSGN remains enigmatic due to different strains. The SpeB proteinase, a pathogenic antigen in PSGN, suspiciously induces cross-reactive antibodies between endothelial cells, cardiac myosin, and valvular tissue. Additionally, angiotensin, cardiorenal responses, and overvolume exacerbate the damaged structure and promote eccentric remodeling (2, 9). Vegetation-like thrombosis (observed in case 2) has been noted in some autopsies during ARF. These thrombi contain macrophages, platelets, and reticular fibers during acute valvulitis, which may explain their disappearance during the second echocardiography after early treatment. Regardless, transesophageal echocardiography is still recommended to rule out potential endocarditis foci. With signs of stage C and D in cases 1 and 2, respectively, referral is essential to evaluate the need for surgery and long-term prophylaxis (4, 7, 10).
All patients were managed according to their diagnosis and referred for long-term observation. We did not administer steroids to case 3 due to a lack of evidence. In case 2, sildenafil was used in response to the history of hemoptysis with pulmonary hypertension. Meanwhile, ivabradine in case 3 was well-tolerated even in a pediatric patient with progressing myocarditis and improved LV ejection fraction, in addition to digoxin. Both require consideration and further trials, as there may be benefits from adult cardiovascular treatments. Prophylactic antibiotics should be considered for all patients, including case 3, due to cardiac involvement until no valvular sequelae are proven during follow-up echocardiography (1, 2, 11).
5.1. Conclusions
Given the long-term effects of post-streptococcal cardiac complications, we emphasize echocardiograms as a more readily available and affordable screening and assessment method, especially in endemic populations. To achieve prevention, advocacy in health systems and further research are needed to limit risk factors and control the spread of GAS and other infectious diseases, which continue to challenge cardiovascular management.
Acknowledgements
References
-
1.
Carapetis JR, Beaton A, Cunningham MW, Guilherme L, Karthikeyan G, Mayosi BM, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2016;2:15084. [PubMed ID: 27188830]. [PubMed Central ID: PMC5810582]. https://doi.org/10.1038/nrdp.2015.84.
-
2.
Satoskar AA, Parikh SV, Nadasdy T. Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis. Nat Rev Nephrol. 2020;16(1):32-50. [PubMed ID: 31399725]. https://doi.org/10.1038/s41581-019-0178-8.
-
3.
Ghosh S, King-Morris K, Shultz J. Concomitant Acute Rheumatic Fever and Acute Post Streptococcal Glomerulonephritis. Cureus. 2021;13(7). e16357. https://doi.org/10.7759/cureus.16357.
-
4.
Rwebembera J, Marangou J, Mwita JC, Mocumbi AO, Mota C, Okello E, et al. 2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease. Nat Rev Cardiol. 2024;21(4):250-63. [PubMed ID: 37914787]. https://doi.org/10.1038/s41569-023-00940-9.
-
5.
Kazahura PT, Mushi TL, Pallangyo P, Janabi M, Kisenge R, Albaghdadi M, et al. Prevalence and risk factors for Subclinical Rheumatic Heart Disease among primary school children in Dar es Salaam, Tanzania: a community based cross-sectional study. BMC Cardiovasc Disord. 2021;21(1):610. [PubMed ID: 34930122]. [PubMed Central ID: PMC8686380]. https://doi.org/10.1186/s12872-021-02377-9.
-
6.
Gewitz MH, Baltimore RS, Tani LY, Sable CA, Shulman ST, Carapetis J, et al. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation. 2015;131(20):1806-18. [PubMed ID: 25908771]. https://doi.org/10.1161/CIR.0000000000000205.
-
7.
Hunter LD, Doubell AF, Pecoraro AJK, Monaghan M, Lloyd G, Lombard CJ, et al. The variable spectrum of anterior mitral valve leaflet restriction in rheumatic heart disease screening. Echocardiography. 2021;38(5):729-36. [PubMed ID: 33847025]. https://doi.org/10.1111/echo.15039.
-
8.
Idhate T, Zaki SA, Shanbag P. Cardiac status in children with acute poststreptococcal glomerulonephritis. Saudi J Kidney Dis Transpl. 2017;28(4):830-5. [PubMed ID: 28748885].
-
9.
Luo YH, Chuang WJ, Wu JJ, Lin MT, Liu CC, Lin PY, et al. Molecular mimicry between streptococcal pyrogenic exotoxin B and endothelial cells. Lab Invest. 2010;90(10):1492-506. [PubMed ID: 20458278]. https://doi.org/10.1038/labinvest.2010.93.
-
10.
Chopra P, Narula JP. Scanning electron microscope features of rheumatic vegetations in acute rheumatic carditis. Int J Cardiol. 1991;30(1):109-12. [PubMed ID: 1991659]. https://doi.org/10.1016/0167-5273(91)90131-8.
-
11.
Sathyamurthy I, Newale S. Ivabradine: Evidence and current role in cardiovascular diseases and other emerging indications. Indian Heart J. 2018;70 Suppl 3(Suppl 3):S435-41. [PubMed ID: 30595304]. [PubMed Central ID: PMC6309574]. https://doi.org/10.1016/j.ihj.2018.08.008.